14/02/19 06:00 UTC-4

The German pharmaceutical company will use the blockchain from IBM

The German pharmaceutical multinational corporation, Boehringer Ingelheim, intends to test IBM's blockchainBlockchain
is a continuous and sequential block chain of information (digital linked list). When building a blockchain, copies of related blocks are simultaneously stored on multiple computers.Details
in Canada to "improve the quality of clinical trials," as reported by CoinDesk.

On Tuesday, February 12th, the Boehringer Ingelheim company (Canada) published a message on collaboration with IBM "in orderOrder
– automatic application to buy or sell cryptocurrency. Orders are used during trading on the stock exchange to open and close a position. Details
to increase trust, transparency, patient safety, empower patients in clinical trials."

Interesting in the section: 0x: development and prospects


IBM Blockchain and pharmaceuticals

The Boehringer Ingelheim company stated that the goal of implementing blockchain technology is to solve the problems of the quality of research and clinical trial records. According to a Boehringer report, currently documentation is often "incomplete and patterned" and can compromise patient safety.

According to the project’s press-release, the blockchain will help create a decentralized structure that preserves "the integrity of the data, ensures transparency and allows automating the processes". Dr. Uli Brödl, vice president of health and regulatory affairs at Boehringer Ingelheim (Canada), commented on the introduction of blockchain-innovation.

"The clinical trial ecosystem is very complex because it involves various stakeholders, which leads to limited trust, lack of transparency and low process efficiency (...) The modern clinical research system works without real empowering patients" – Dr. Uli Brödl.

Claude Guay, IBM's general service manager, also commented on the collaboration: "We have already used blockchain in various industries (...) now we are exploring how this technology can be used to give Canadian patients a high level of security and trust to work with their personal health information."

Interesting in the section: Blokchain technology outside cryptocurrencies

A German pharmaceutical company has announced the use of the IBM blockchain to work effectively with clinical research in Canada. Recall that other major pharmaceutical companies are also exploring the potential benefits of integrating blockchain technology. In January 2018, Pfizer, Amgen and Sanofi also looked at the blockchain to optimize the process of developing and testing new drugs.

Editor: Alyona Nabok

See also: "Mitsubishi UFJ announced the launch of a new blockchain-based payment system"

#blockchain #Germany #Canada #BoehringerIngelheim #blockchain #medicine #IBM



17/05/19 06:00 UTC-4

#DropGold Bitcoin movement is now on American TV channels

​On May 16, it was reported that the popular American TV channels, National Geographic and Fox News, will broadcast a video ad for the DropGold movement. As it became known, the project was financed by Grayscale Investments and Barry Silbert.

03/05/19 09:00 UTC-4

Vitalik Buterin: Ethereum for people!

​On May 3rd, the Ethereum cryptocurrency developer stated that Ethereum coins are intended primarily for ordinary people. According to Vitalik Buterin, cryptocurrencies should become easier and more reliable.

20/05/19 10:08 UTC-4

WhatsApp messenger now supports Bitcoin and Litecoin payments

​On Sunday, May 19th, developers from the Zulu Republic team reported on the implementation of a special bot for crypto transactions inside the WhatsApp messenger. Now the WhatsApp network can make payments in Bitcoins and Litecoin.

Hypes, funds, fiat money